Skip to main content
TipRanks
Go Ultimate75% OFF

Nurix Therapeutics (NRIX) Drug Pipeline

613 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Venetoclax, Rituximab, Obinutuzumab, Nx-5948Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, B-Cell Lymphomaphase1AndPhase2RecruitingStudy of NX-5948 in Combination With Other Agents in Adults With B-cell MalignanciesApr 02, 2026―
Pirtobrutinib, Nx-5948Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, B-Cell LymphomaPhase IIINot Yet RecruitingStudy of NX-5948 Versus Pirtobrutinib in R/R CLL/SLLMar 31, 2026
Nx-5948Small Lymphocytic Lymphoma (Sll), Chronic Lymphocytic Leukemia (Cll)Phase IIRecruitingA Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)Oct 24, 2025
Esomeprazole, Nx-5948 Capsule, Nx-5948 TabletHealthy VolunteerPhase IRecruitingRelative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 TabletsDec 01, 2024
Nx-5948Healthy VolunteerPhase ICompletedAbsolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948Nov 01, 2024―
IpHealthy VolunteersPhase ICompletedA Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult SubjectsSep 05, 2024―
Nx-5948Diffuse Large B Cell Lymphoma (Dlbcl), Marginal Zone Lymphoma (Mzl), Follicular Lymphoma (Fl), Small Lymphocytic Lymphoma (Sll), Chronic Lymphocytic Leukemia (Cll), Mantle Cell Lymphoma (Mcl), Primary Central Nervous System Lymphoma (Pcnsl), Waldenstrom Macroglobulinemia (Wm), Secondary Central Nervous System Lymphoma (Scnsl)Phase IRecruitingA Study of NX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesNov 12, 2021
Paclitaxel, Nx-1607Gastroesophageal Junction (Gej) Cancer, Ovarian Cancer, Epithelial, Metastatic Urothelial Carcinoma, Metastatic Or Unresectable Melanoma, Richter Transformation, Metastatic Castration-Resistant Prostate Cancer (Mcrpc), Malignant Pleural Mesothelioma (Mpm), Triple Negative Breast Cancer (Tnbc), Non-Small Cell Lung Cancer (Nsclc), Cervical Cancer, Gastric Cancer, Head And Neck Squamous Cell Carcinoma, Diffuse Large B Cell Lymphoma (Dlbcl), Microsatellite Stable Colorectal CarcinomaPhase IRecruitingA Study of NX-1607 in Adults With Advanced MalignanciesSep 22, 2021
Nx-2127Marginal Zone Lymphoma (Mzl), Follicular Lymphoma (Fl), Small Lymphocytic Lymphoma (Sll), Mantle Cell Lymphoma (Mcl), Diffuse Large B-Cell Lymphoma (Dlbcl), Chronic Lymphocytic Leukemia (Cll), Primary Central Nervous System Lymphoma (Pcnsl), Waldenstrom Macroglobulinemia (Wm)Phase IRecruitingA Study of NX-2127 in Adults With Relapsed/Refractory B-cell MalignanciesMar 29, 2021

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Nurix Therapeutics, Inc. (NRIX) have in its pipeline
Nurix Therapeutics NRIX is currently developing the following drugs: Venetoclax, Rituximab, Obinutuzumab, Nx-5948, Pirtobrutinib, Nx-5948, Nx-5948, Esomeprazole, Nx-5948 Capsule, Nx-5948 Tablet, Ip, Paclitaxel, Nx-1607, Nx-2127. These drug candidates are in various stages of clinical development as the company works toward FDA approval.